Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seger

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Trauma|January 1, 1995
A prospective study of the performance of the trauma team leaderM Sugrue, M Seger, R Kerridge, et al.
Parasite Immunology|June 1, 1993
The schistosomulicidal activity and the production of IL-1 and TNF-alpha by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide-phosphatidyl ethanolamine (MTP-PE) treatmentM Seger, D Gold, J Lengy, et al.
Parasite Immunology|July 1, 1992
On the interaction between macrophages and developmental stages of Schistosoma mansoni: effect of muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) treatment on mice survival and the generation of schistosomulicidal macrophagesM Seger, D Gold, J Lengy, et al.
Journal of Neurobiology|November 1, 1976
Neuron culture from adult goldfishU De Boni, M Seger, J W Scott, et al.
Irish Journal of Medical Science|April 1, 1996
Trauma outcomes: a death analysis studyM Sugrue, M Seger, D Sloane, et al.
Immunobiology|August 1, 1993
IL-1, TNF-alpha and IL-2 production by peritoneal and spleen cells from Schistosoma mansoni infected mice and its potentiation by preimmunization with schistosomal antigens and immunostimulantsY Keisari, M Seger, J Lengy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1983
Technetium-99m glucoheptonate imaging in lung cancer and benign lung disease: concise communicationP M Passamonte, R M Seger, R A Holmes, et al.
Computer Methods and Programs in Biomedicine|February 22, 2005
Lead field computation for the electrocardiographic inverse problem--finite elements versus boundary elementsM Seger, G Fischer, R Modre, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetesH Linnebjerg, P A Kothare, M Seger, et al.
The Open Medical Informatics Journal|May 6, 2009
Patient-specific volume conductor modeling for non-invasive imaging of cardiac electrophysiologyB Pfeifer, F Hanser, M Seger, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Trauma|January 1, 1995
A prospective study of the performance of the trauma team leaderM Sugrue, M Seger, R Kerridge, et al.
Parasite Immunology|June 1, 1993
The schistosomulicidal activity and the production of IL-1 and TNF-alpha by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide-phosphatidyl ethanolamine (MTP-PE) treatmentM Seger, D Gold, J Lengy, et al.
Parasite Immunology|July 1, 1992
On the interaction between macrophages and developmental stages of Schistosoma mansoni: effect of muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) treatment on mice survival and the generation of schistosomulicidal macrophagesM Seger, D Gold, J Lengy, et al.
Journal of Neurobiology|November 1, 1976
Neuron culture from adult goldfishU De Boni, M Seger, J W Scott, et al.
Irish Journal of Medical Science|April 1, 1996
Trauma outcomes: a death analysis studyM Sugrue, M Seger, D Sloane, et al.
Immunobiology|August 1, 1993
IL-1, TNF-alpha and IL-2 production by peritoneal and spleen cells from Schistosoma mansoni infected mice and its potentiation by preimmunization with schistosomal antigens and immunostimulantsY Keisari, M Seger, J Lengy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1983
Technetium-99m glucoheptonate imaging in lung cancer and benign lung disease: concise communicationP M Passamonte, R M Seger, R A Holmes, et al.
Computer Methods and Programs in Biomedicine|February 22, 2005
Lead field computation for the electrocardiographic inverse problem--finite elements versus boundary elementsM Seger, G Fischer, R Modre, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetesH Linnebjerg, P A Kothare, M Seger, et al.
The Open Medical Informatics Journal|May 6, 2009
Patient-specific volume conductor modeling for non-invasive imaging of cardiac electrophysiologyB Pfeifer, F Hanser, M Seger, et al.
Pageof 5